The group on semaglutide only experienced 794 fractures, while the control group experienced 1,045
products may contain contaminants, adulterants, or unlisted substances Allergic reactions : Adhesive components and botanical extracts can cause contact dermatitis, skin irritation, or systemic allergic responses Drug interactions : Herbal ingredients may interact with prescription medications, including anticoagulants, antihypertensives, or diabetes medications False reassurance : Belief in patch efficacy may lead patients to neglect dietary modifications, physical activity, or medication adherence The financial burden represents another limitation
Metreleptin, which replaces the adipocyte hormone leptin, is the only specific treatment to alleviate the metabolic complications of lipodystrophy and can also offer significant improvements in quality of life (810)
Lilly's diabetes drug Mounjaro receives expanded approval for weight management in Korea Novo Nordisks weight-loss drugs see over 1.1 million prescriptions in Korea, raising misuse concerns Jeong Min-jun [email protected]
"Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study"